Detalles de la búsqueda
1.
Real-world evidence data on the monoclonal antibody erenumab in migraine prevention: perspectives of treating physicians in Germany.
J Headache Pain;
22(1): 133, 2021 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34742252
2.
Electrocardiographic assessments and cardiac events after fingolimod first dose - a comprehensive monitoring study.
BMC Neurol;
17(1): 11, 2017 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-28100182
3.
Addition of quantitative MRI to the routine clinical care of patients with multiple sclerosis-Results from the MAGNON project.
Brain Behav;
14(6): e3548, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841819
4.
Large-scale cross-sectional online survey on patient-neurologist communication, burden of disease assessment and disease monitoring in people with multiple sclerosis.
Front Neurol;
13: 1093352, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36686532
5.
Patient satisfaction and healthcare services in specialized multiple sclerosis centres in Germany.
Ther Adv Neurol Disord;
11: 1756285617748845, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-29399052
6.
Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN.
Ther Adv Neurol Disord;
9(5): 378-88, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27582893
7.
Acceptance of the extracare program by Beta interferon-treated patients with multiple sclerosis: results of the explore study.
J Neurosci Nurs;
47(1): E31-9, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25285595
8.
Inhibition of the MAP kinase ERK protects from lipopolysaccharide-induced lung injury.
Biochem Pharmacol;
77(12): 1827-34, 2009 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19428337
Resultados
1 -
8
de 8
1
Próxima >
>>